Ngwadogwu maka Ọkpụkpụ Osteoarthritia
Monovisc bụ otu viscosupment na- ejide onwe ya iji mesoo nkwonkwo ikpere nke ọrịa ogbu na nkwonkwo na-emetụta. Ọ bụ ọgwụ ogwugwu , nke pụtara, a na-agbanye ya n'ime nkwonkwo emetụtara. Anika Therapeutics, Inc. nwetara Monovisc ma nata nkwado ahịa site n'aka US FDA na February 25, 2014. Mpịv Synthes, Mitek Sports Medicine na-ere ahịa Monovisc, n'okpuru nkwekọrịta ikike na Anika.
Hyaluronan (shuga dị mgbagwoju anya nke ezinụlọ glycosaminoglycan) na Monovisc bụ arọ dị arọ dị arọ, ihe mgbapụta dị elu dị ọcha nke hyaluronan sitere n'okike na-abụghị anụmanụ. A na-enweta hyaluronan site na mkpụrụ ndụ bacteria ma jikọta ya na ihe ngwọta. Monovisc na-enye ụdị ọgwụgwọ yiri ya na Orthovisc , ọzọ Anika Therapeutics viscosupplement - ma Orthovisc na-eduzi na usoro nke atọ injections kama otu ogwu.
Ntu
E gosipụtara Monovisc maka ọgwụgwọ nke ikpere osteoarthritis na ọrịa ndị na-emezughị ọgwụgwọ na-agbanwe agbanwe, dịka ọgwụgwọ ndị na-abụghị ọgwụ na ọgwụ ndị na-abụghị ọgwụ ọjọọ (eg, acetaminophen ). Ihe bụ isi e ji amata ikuku osteoarthritis bụ mmebi nke cartilage nke na-akpata oké ihe mgbu na mkpirikpi nke nrụgide n'ime njikọ ahụ metụtara. N'ọrịa ogbu na nkwonkwo, enwere ihe mgbagwoju anya na mmiri synovial . Mmiri na-arụ ọrụ nke ọma na-eme ka nkwonkwo dị na ya, na-enye ohere maka esemokwu n'enweghị nsogbu.
Ndachapu, dị ka Monovisc na ndị ọzọ ndị a kwadoro tupu oge ahụ, laghachiri na-eme ka ndị ọzọ nweta ihe ha na-eme.
Ihe Omumu
Data nchekwa na irè site na nchịkọta nke ọmụmụ ihe omimi, nke a na-achịkwa, bụ nke nwere 369 ndị na-amụ na osteoarthritis ikpere n'ala 31 na US na Canada bụ ihe ndabere maka nkwado FDA nke Monovisc, dị ka Anika Therapeutics.
E kenyere ndị na-eso ụzọ Monovisc ma ọ bụ saline injections (njikwa). A tụlere ha maka mmụba nke nkwonkwo mgbu site na iji WOMAC (n'Ebe Ọdịda Anyanwụ Ontario na McMaster Universities Osteoarthritis Index), na-achọ ndị ọrịa Monovisc nke nwetara nhụzi ka mma na akara WOMAC ma e jiri ya tụnyere ndị na-agwọ ọrịa ihe karịrị izu iri na abụọ. Mpaghara nchekwa nke nyocha ahụ kpughere "ọnụ ọgụgụ dị oke ala nke ihe ọjọọ" ma ọ bụ ihe ọjọọ na Monovisc.
Ihe Ntuzi ndi ozo
A kwadoro nlezianya mbụ na 1997. E nwere ugbu a nlezianya ndị ọzọ 5, ọtụtụ n'ime ha na-achọ usoro injections karịa otu nkedo.
- Hyalgan
- Synvisc na Synvisc-Otu (otu ogwu mere site na ọkụkọ ọkụkọ)
- Tụgharịa
- Orthovisc
- Euflexxa
Mmetụta nke Viscosupplementation
N'afọ 2012, otu akụkọ e bipụtara na Annals of Internal Medicine kwubiri na viscosupmentation adịghị arụ ọrụ ma dị ize ndụ. Akuko ahụ kwuru na viscosupmentation na-emepụta mbelata ihe mgbu na-adịghị mkpa ma ọ nwere ike ịba ụba nke ihe ọkụkụ na ihe ọjọọ. Nkwubi okwu a dabeere na nchịkọta nyocha nke nje 89 na-akpata ihe karịrị mmadụ 12,000 na-arịa ọrịa ogbu na nkwonkwo.
Ụlọ akwụkwọ American Academy of Orthopedic Surgeons na-ekwu na "Ọhụụ na-enye aka maka ndị ọrịa ogbu na nkwonkwo anabataghị ọgwụgwọ ndị dị na ya. Ọ dị irè ma ọ bụrụ na ọrịa ogbu na nkwonkwo dị na mmalite (dị nwayọọ ruo n'ókè). ọ bụrụ na ọ bụrụ na ọnyá ahụ dị irè, ha nwere ike ịmeghachi ya mgbe oge ụfọdụ gasịrị, ma ọ bụrụ na ọ bụrụ na ọnyá ndị ahụ na - emekarị ọnwa 6. Ọ dịbeghị anya ọganihu nke viscosupplementation ka a ma ama na nchọpụta na-aga n'ihu na mpaghara a. "
> Isi mmalite:
> FDA kwadoro Monovisc, Ọgwụgwọ Ọgwụ Ọhụrụ Na-agwọ Ọgwụ maka Ọgwụgwọ Nhụjuanya n'ihi Osteoarthritis nke Knee. Anika Therapeutics. Febụwarị 25, 2014.
Ngwakọta ngwongwo nke Osteoarthritis of the Knee: A Review System and Meta-analysis. Ọgọst 7, 2012. Rutjes et al. Ndekọ nke Ọgwụ Ọgwụ.
> Ọgwụgwọ Viscosupplementation maka Ọrịa Ogbu na nkwonkwo. OrthoInfo. AAOS. April 2013.